Opinion

Video

Metastatic Prostate Cancer: Background and Patient Prognosis

An expert provides an overview of metastatic prostate cancer, including information on how it advances, patient prognosis, and what factors influence outcomes.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected

      Newsletter

      Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

      Subscribe Now!
      Related Videos
      Rana McKay, MD, outlines key findings from the phase 2 COMRADE trial
      Rana McKay, MD, outlines key findings from the phase 2 COMRADE trial
      4 experts in this video
      Early Recurrent Low-Grade, Intermediate-Risk NMIBC
      Timothy McClure, MD, on next steps for focal therapy in prostate cancer
      Timothy McClure, MD, on next steps for focal therapy in prostate cancer
      Related Content
      Survey data shows lack of awareness on prostate, testicular cancer
      August 29th 2025

      Survey data shows lack of awareness on prostate, testicular cancer

      Hannah Clarke
      Pearls & Perspectives: Treating Male Pelvic Floor Dysfunction, with Adam Gvili, PT, DPT
      August 29th 2025

      Pearls & Perspectives: Treating Male Pelvic Floor Dysfunction, with Adam Gvili, PT, DPT

      Amy M. Pearlman, MD
      Downloaded Save to Library Preview Crop Find Similar File #: 322782977 Abstract tech background made of printed circuit board. Depth of field effect and bokeh. internet connections, cloud computing and neural network, big data. 3D render | Image Credit: © Quardia Inc. - stock.adobe.com
      August 29th 2025

      AI and prostate cancer: Balancing hope and caution

      Christopher Weight, MD, MS
      First Assist: The Historical Context of Advanced Kidney Cancer, with Eric A. Singer, MD
      August 29th 2025

      First Assist: The Historical Context of Advanced Kidney Cancer, with Eric A. Singer, MD

      Taylor Goodstein, MD
      Health Canada approves darolutamide for metastatic castration-sensitive prostate cancer
      August 29th 2025

      Health Canada approves darolutamide for metastatic castration-sensitive prostate cancer

      Hannah Clarke
      Positive data on BOTRESO and MCS-8 highlight dual advances in prostate health
      August 29th 2025

      Positive data on BOTRESO and MCS-8 highlight dual advances in prostate health

      Hannah Clarke
      © 2025 MJH Life Sciences

      All rights reserved.